Sign inJoin waitlistJoin the waitlist

Ben Ebert

President and CEO, Dana-Farber Cancer Institute · Mass General Brigham

Credentials: · · ·

History

Boston University Medical Center
Present

Hematology and Medical Oncology
Dana-Farber Cancer Institute
The Broad Institute of Harvard and MIT
Internal Medicine
Massachusetts General Hospital
Oxford University
Harvard Medical School
Williams College

Research

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles
Proceedings of the National Academy of Sciences of the United States of America · 2005 · 42,560 citations
MicroRNA expression profiles classify human cancers
Nature · 2005 · 7,714 citations
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Review · Blood · 2017 · 4,728 citations

Pradeep Natarajan
42 papers
CG
Christopher Gibson
39 papers
Alexander Bick
37 papers · 11 as a resident
Siddhartha Jaiswal
33 papers · 5 as a resident
AS
Adam Sperling
31 papers · 3 as a fellow
Ross Levine
27 papers · 2 as a fellow
Peter Libby
25 papers
DS
David Steensma
24 papers
Todd Golub
23 papers
Ann Mullally
21 papers · 7 as a fellow
Rafael Bejar
19 papers
Coleman Lindsley
18 papers · 4 as a fellow

Grants

Development of Novel Therapeutic Strategies in Human Leukemias
National Cancer Institute · P01
Contact PI · $23.5M · Dana-Farber Cancer Inst
1997–2030
The Role of Clonal Hematopoiesis in the Development and Therapy of Myeloid Malignancies
National Cancer Institute · R35
Contact PI · $4.9M · Dana-Farber Cancer Inst
2020–2027
Dana-Farber/Harvard Cancer Center
National Cancer Institute · P30
Contact PI · $38.9M · Dana-Farber Cancer Inst
1997–2026
Functional Genomic Dissection of Refractory Anemia
National Heart, Lung, and Blood Institute · R01
Contact PI · $5.6M · Dana-Farber Cancer Inst
2005–2024